0001140361-15-025097.txt : 20150622
0001140361-15-025097.hdr.sgml : 20150622
20150622215721
ACCESSION NUMBER: 0001140361-15-025097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150618
FILED AS OF DATE: 20150622
DATE AS OF CHANGE: 20150622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Raptor Pharmaceutical Corp
CENTRAL INDEX KEY: 0001070698
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860883978
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 HAMILTON LANDING
STREET 2: SUITE 100
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-408-6200
MAIL ADDRESS:
STREET 1: 7 HAMILTON LANDING
STREET 2: SUITE 100
CITY: NOVATO
STATE: CA
ZIP: 94949
FORMER COMPANY:
FORMER CONFORMED NAME: Raptor Pharmaceutical Corp.
DATE OF NAME CHANGE: 20090929
FORMER COMPANY:
FORMER CONFORMED NAME: TorreyPines Therapeutics, Inc.
DATE OF NAME CHANGE: 20061003
FORMER COMPANY:
FORMER CONFORMED NAME: AXONYX INC
DATE OF NAME CHANGE: 19990303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daley Thomas E
CENTRAL INDEX KEY: 0001420859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25571
FILM NUMBER: 15946000
MAIL ADDRESS:
STREET 1: C/O RAPTOR PHARMACEUTICALS CORP.
STREET 2: 9 COMMERCIAL BLVD., SUITE 200
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2015-06-18
0
0001070698
Raptor Pharmaceutical Corp
RPTP
0001420859
Daley Thomas E
C/O RAPTOR PHARMACEUTICAL CORP.
7 HAMILTON LANDING, SUITE 100
NOVATO
CA
94949
0
1
0
0
Chief Business Officer
Common Stock
2015-06-18
4
S
0
30000
15.00
D
34719
D
Common Stock
2015-06-18
4
M
0
5000
3.54
A
39719
D
Common Stock
2015-06-18
4
S
0
5000
15.00
D
34719
D
Common Stock
3.54
2015-06-18
4
M
0
5000
0
A
2020-11-22
Stock options (right to buy)
5000
62864
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014.
Includes 11,500 Restricted Stock Units ("RSUs") granted on February 9, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
Fully vested and exercisable.
/s/ Mark Jones, Raptor Pharmaceutical Corp., Attorney-in-Fact
2015-06-22